Two decisions from the European Patent Office offer important guidance for healthcare inventions that use computers, says Rosie McDowell of EIP.
- CMA costs case improves access to justice 30-06-2022
- WTO's COVID deal: more vaccine ‘enabler’ than IP waiver? 23-06-2022
- Gilenya injunction bid: big pharma takeaways 21-06-2022
- Why the ‘first penguin’ of pay for delay has not come in Japan: anatomy of a Japan paradox 27-05-2022
- Gene-editing bill: encouraging innovation or adding complexity? 26-05-2022
Dispute over the Enhertu began in 2019 | Antibody drug conjugate tech at issue | American Arbitration Association issued final decision.